Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Prognostic impact of tissue factor pathway on long-term ischemic events of ST-elevated myocardial infarction treated with a primary percutaneous coronary intervention.

Sambola A, García Del Blanco B, Francisco J, Figueras J, Martí G, Roca I, Otaegui I, García-Dorado D.

Int J Cardiol. 2013 Oct 3;168(3):2916-8. doi: 10.1016/j.ijcard.2013.03.188. Epub 2013 May 1. No abstract available.

PMID:
23642812
2.

Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).

Kirtane AJ, Sandhu P, Mehran R, McEntegart M, Cristea E, Brener SJ, Xu K, Fahy M, Généreux P, Wessler JD, Stone GW.

Am J Cardiol. 2014 Jan 1;113(1):36-43. doi: 10.1016/j.amjcard.2013.08.034. Epub 2013 Oct 2.

PMID:
24169019
3.

Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Lindberg S, Pedersen SH, Mogelvang R, Jensen JS, Flyvbjerg A, Galatius S, Magnusson NE.

J Am Coll Cardiol. 2012 Jul 24;60(4):339-45. doi: 10.1016/j.jacc.2012.04.017.

4.

Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.

Fuernau G, Zaehringer S, Eitel I, de Waha S, Droppa M, Desch S, Schuler G, Adams V, Thiele H.

Int J Cardiol. 2013 Sep 1;167(5):2134-9. doi: 10.1016/j.ijcard.2012.05.101. Epub 2012 Jun 15.

PMID:
22704876
5.

Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).

Loh JP, Pendyala LK, Kitabata H, Torguson R, Omar A, Minha S, Chen F, Satler LF, Pichard AD, Waksman R.

Am J Cardiol. 2014 Jun 1;113(11):1794-801. doi: 10.1016/j.amjcard.2014.03.007. Epub 2014 Mar 15.

PMID:
24837256
6.

Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.

Niccoli G, Celestini A, Calvieri C, Cosentino N, Falcioni E, Carnevale R, Nocella C, Fracassi F, Roberto M, Antonazzo RP, Pignatelli P, Crea F, Violi F.

Eur Heart J Acute Cardiovasc Care. 2013 Dec;2(4):379-88. doi: 10.1177/2048872613504698. Epub 2013 Sep 5.

7.

The prognostic value of plasma fibrinogen concentrations of patients with ST-elevation myocardial infarction and treated by primary percutaneous coronary intervention: a cautionary message.

Ferraro S, Santagostino M, Marano G, Colli E, Vendramin C, Maffé S, Rossi L, Galvani M, Panteghini M, Bongo AS.

Scand J Clin Lab Invest. 2012 Sep;72(5):355-62. doi: 10.3109/00365513.2012.671491. Epub 2012 Apr 10.

PMID:
22486807
8.

Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.

Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2252-60. doi: 10.1161/ATVBAHA.113.301586. Epub 2013 Jul 18.

9.

Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.

Farkouh ME, Reiffel J, Dressler O, Nikolsky E, Parise H, Cristea E, Baran DA, Dizon J, Merab JP, Lansky AJ, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2013 Jun;6(3):216-23. doi: 10.1161/CIRCINTERVENTIONS.112.000142. Epub 2013 May 7.

10.

Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort.

Jones DA, Gallagher S, Rathod KS, Akhtar M, Knight CJ, Rothman MT, Kapur A, Mathur A, Jain AK, Timmis AD, Smith EJ, Wragg A.

Am J Cardiol. 2013 Nov 1;112(9):1347-54. doi: 10.1016/j.amjcard.2013.07.002. Epub 2013 Sep 5.

PMID:
24012030
11.

Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Porto I, De Maria GL, Leone AM, Dato I, D'Amario D, Burzotta F, Niccoli G, Trani C, Biasucci LM, Bolognese L, Crea F.

Am J Cardiol. 2013 Sep 15;112(6):782-91. doi: 10.1016/j.amjcard.2013.04.056. Epub 2013 Jun 6.

PMID:
23746481
12.

Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.

White HD, Chew DP, Dauerman HL, Mahaffey KW, Gibson CM, Stone GW, Gruberg L, Harrington RA, Bhatt DL.

Am Heart J. 2012 Feb;163(2):182-90.e4. doi: 10.1016/j.ahj.2011.11.001.

PMID:
22305835
13.

Long-term prognostic value of mitral regurgitation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

López-Pérez M, Estévez-Loureiro R, López-Sainz A, Couto-Mallón D, Soler-Martin MR, Bouzas-Mosquera A, Peteiro J, Barge-Caballero G, Prada-Delgado O, Barge-Caballero E, Salgado-Fernández J, Calviño-Santos R, Vázquez-Rodríguez JM, Piñón-Esteban P, Aldama-López G, Vázquez-González N, Castro-Beiras A.

Am J Cardiol. 2014 Mar 15;113(6):907-12. doi: 10.1016/j.amjcard.2013.11.050. Epub 2013 Dec 25.

PMID:
24461770
14.

Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Yu J, Mehran R, Dangas GD, Claessen BE, Baber U, Xu K, Parise H, Fahy M, Lansky AJ, Witzenbichler B, Grines CL, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone GW.

JACC Cardiovasc Interv. 2012 Dec;5(12):1231-8. doi: 10.1016/j.jcin.2012.07.016.

15.

Long term prognostic value of subclinical carotid and femoral arterial wall lesions in patients with ST-elevation-myocardial infarction having percutaneous coronary intervention.

Monopoli DE, Bertelli L, Sgura FA, Politi L, Becirovic M, Iaccarino D, Lattanzi A, Rampino K, Gorlato G, Menozzi M, Zennaro RG, Rossi R.

Am J Cardiol. 2013 Mar 1;111(5):649-56. doi: 10.1016/j.amjcard.2012.11.014. Epub 2012 Dec 13. Erratum in: Am J Cardiol. 2013 May 1;111(9):1375. Modena, Maria Grazia [removed].

PMID:
23246270
16.

Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.

Davies WR, Brown AJ, Watson W, McCormick LM, West NE, Dutka DP, Hoole SP.

Circ Cardiovasc Interv. 2013 Jun;6(3):246-51. doi: 10.1161/CIRCINTERVENTIONS.112.000184. Epub 2013 May 21.

17.

Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era.

Nakatani D, Sakata Y, Suna S, Usami M, Matsumoto S, Shimizu M, Hara M, Uematsu M, Fukunami M, Hamasaki T, Sato H, Hori M, Komuro I; Osaka Acute Coronary Insufficiency Study (OACIS) Investigators.

Am J Cardiol. 2013 Feb 15;111(4):457-64. doi: 10.1016/j.amjcard.2012.10.026. Epub 2012 Dec 8.

PMID:
23228922
18.

Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Ng S, Ottervanger JP, van 't Hof AW, de Boer MJ, Reiffers S, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H.

Int J Cardiol. 2013 May 25;165(3):523-7. doi: 10.1016/j.ijcard.2011.09.082. Epub 2011 Oct 14.

PMID:
22000421
19.

Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).

Rene AG, Généreux P, Ezekowitz M, Kirtane AJ, Xu K, Mehran R, Brener SJ, Stone GW.

Am J Cardiol. 2014 Jan 15;113(2):236-42. doi: 10.1016/j.amjcard.2013.09.016. Epub 2013 Oct 3.

PMID:
24176066
20.

Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Pedersen S, Mogelvang R, Bjerre M, Frystyk J, Flyvbjerg A, Galatius S, Sørensen TB, Iversen A, Hvelplund A, Jensen JS.

Cardiology. 2012;123(1):31-8. doi: 10.1159/000339880. Epub 2012 Sep 7.

Items per page

Supplemental Content

Write to the Help Desk